Global Pulmonary Drug Delivery Market is Rising at a CAGR of 7.0% During the Anticipated Period of 2017 to 2024

Pulmonary Drug Delivery Market is forecast to grow at a CAGR of 7.0% for the forecast period of 2017 to 2024 to an estimated value of USD 36.50 billion in 2016 with factors such as the regulatory concerns and stability issues coupled the products which are hindering the growth of the market.

Moreover, the increasing technological advancement will further boost various new opportunities that will fuel the growth of the pulmonary drug delivery market in the above mentioned forecast period.

Pulmonary Drug Delivery Market Scenario

According to Data Bridge Market Research, the pulmonary drug delivery market in developing regions is witnessing a growth in terms of its adoption rate, due to the rising prevalence of respiratory diseases and increasing focus on the growth of smart digital inhalers. Increasing advances in device technology is also anticipated to enhance the growth of pulmonary drug delivery market in the forecast period of 2017 to 2024.

Now the question is which are the other regions that pulmonary drug delivery market players should target? Data Bridge Market Research has forecasted North America to dominate the pulmonary drug delivery market.

For more analysis on the pulmonary drug delivery market, request for a briefing with our analysts

Pulmonary Drug Delivery Market Development

  • In October 2019, West had launched its two new products offerings, the NovaPure 3mL and SmartDose Gen. II 10mL injector proposed for regular delivery for advanced volume injectable drug delivery systems. This product launch will help the company to enhance its product portfolio in the market.

Pulmonary Drug Delivery Market Scope

Pulmonary drug delivery market is segmented on the basis of countries into the U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Israel, Egypt, South Africa, Rest of Middle East and Africa.

  • All country based analysis of the pulmonary drug delivery market is further analyzed based on maximum granularity into further segmentation. On the basis of type, the pulmonary drug delivery market is segmented into dry powder inhalers, nebulizers, metered dose inhalers, solution aerosols, and suspension aerosols. On the basis of application, the pulmonary drug delivery market is segmented into chronic obstructive pulmonary disease, asthma, cystic fibrosis, and other applications. On the basis of end-user, the pulmonary drug delivery market is segmented into hospitals & clinics, and home care settings. Based on the distribution channel, the pulmonary drug delivery market is segmented into retail pharmacies, hospital pharmacies, and E-commerce.
  • Pulmonary drug delivery is the most efficient manner of drug delivery in respiratory diseases as the lungs proffer a huge surface area of alveoli with huge capillary network that offers an exceptional captivating surface for administration of drugs

To know more about the study

Key Pointers Covered in the Pulmonary Drug Delivery Market Industry Trends and Forecast to 2024

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the Report

  • GlaxoSmithKline plc
  • 3M
  • AstraZeneca
  • Boehringer Ingelheim GmbH
  • Koninklijke Philips N.V.
  • PARI
  • GF Health Products Inc
  • Merck & Co., Inc
  • Progressive Trade Media Limited
  • BeyonDevices
  • Lda
  • Aphios
  • AptarGroup, Inc
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • TTP plc
  • Hovione
  • Teva Pharmaceutical Industries Ltd
  • OMRON Corporation
  • Catalent, Inc
  • Sunovion Pharmaceuticals Inc.

Above are the key players covered in the report, to know about more and exhaustive list of pulmonary drug delivery companies’, contact us

Research Methodology of Global Pulmonary Drug Delivery Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecast using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global Vs Regional Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@